The immune dysregulation triggered by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been hypothesised as a causal pathway for the increasingly reported oral manifestations associated with coronavirus diseases (COVID‐19) especially the ones of fungal origin.1–3 As a result of this, we aim to report according to the CARE guidelines, three COVID‐19 cases who sought teleconsultations from our private practice (Cairo, Egypt) from July to September 2020. In addition, we have performed a literature search in Ovid MEDLINE®, EMBASE, Cochrane Library, and Epistemonikos from inception until November 30th, 2020 with a combination of keywords (COVID‐19 OR SARS‐CoV‐2) AND oral candidiasis.